Frank D. Gianfrancesco
HECON Associates
Inc., Montgomery Village
USA
Name/email consistency: low
- The influence of study design on the results of pharmacoepidemiologic studies of diabetes risk with antipsychotic therapy. Gianfrancesco, F., Wang, R.H., Nasrallah, H.A. Ann. Clin. Psychiatry (2006)
- Effects of patients with bipolar, schizophrenic, and major depressive disorders on the mental and other healthcare expenses of family members. Gianfrancesco, F.D., Wang, R.H., Yu, E. Soc. Sci. Med (2005)
- Relationship between initial quetiapine dose and effectiveness as reflected in subsequent mental health service use among patients with schizophrenia or bipolar disorder. Gianfrancesco, F., Wang, R.H., Pesa, J. Value. Health (2005)
- Antipsychotic-induced type 2 diabetes: evidence from a large health plan database. Gianfrancesco, F., White, R., Wang, R.H., Nasrallah, H.A. J. Clin. Psychopharmacol (2003)